Pheniramine (Maleate)

Overview

Primary Characterstics

Molecular Structure of Pheniramine (Maleate)

Pheniramine (Maleate) is also known as Feniramin, Feniramin, Feniramin.Pheniramine (Maleate) is also known as Feniramin, Feniramin, Feniramin. It is of Synthetic origin and belongs to Alkylamine. It belongs to H1-antagonist pharmacological group on the basis of mechanism of action and also classified in Antihistamine, Decongestant Combination pharmacological group.The Molecular Weight of Pheniramine (Maleate) is 356.40.

Its pKa is 4.2, 9.3.

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Pheniramine (Maleate) is contraindicated in conditions like Prostatic hypertrophy, Hypersensitivity.

Back to top

Drug Interactions

No data regarding the interactions of Pheniramine (Maleate) was found.

Back to top

Side Effects

Back to top

Dosage

Pheniramine (Maleate)'s dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage
25 to 150 mg88 (87.5)24 hourlyMay be given twice daily
12.5 to 25 mg19 (18.75)12 hourlyPOinitial dose, if necessary, may be increased upto 25 mg. Frequency may be increased to 3 times if needed.

Paedriatic Dosage (20kg)
0.726 to 1.816 mg/kg1.3 (1.271)24 hourlyIntra Muscular-
0.75 mg/kg0.75 (0.75)8 hourlyOralDose for 1-3 Yrs of Children

Neonatal Dosage (3kg)
1.13 to 2.83 mg/kg2 (1.98)24 hourlyIntramuscularFor above 6 month of child

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Pheniramine (Maleate)

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages